Gabelli Funds LLC Has $2.64 Million Stock Holdings in Cutera, Inc. (NASDAQ:CUTR)

Gabelli Funds LLC cut its position in shares of Cutera, Inc. (NASDAQ:CUTRFree Report) by 3.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 437,900 shares of the medical device company’s stock after selling 16,200 shares during the quarter. Gabelli Funds LLC owned 2.20% of Cutera worth $2,636,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of CUTR. Point72 Asset Management L.P. bought a new position in shares of Cutera during the second quarter worth about $14,677,000. Bank of Montreal Can bought a new position in Cutera in the second quarter valued at approximately $10,963,000. Hawk Ridge Capital Management LP bought a new position in Cutera in the second quarter valued at approximately $6,414,000. Marshall Wace LLP grew its stake in Cutera by 67.6% in the second quarter. Marshall Wace LLP now owns 909,972 shares of the medical device company’s stock valued at $13,768,000 after purchasing an additional 367,048 shares in the last quarter. Finally, Polar Asset Management Partners Inc. bought a new position in Cutera in the second quarter valued at approximately $4,146,000.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Stifel Nicolaus decreased their price target on Cutera from $20.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, November 9th. Stephens restated an “overweight” rating and issued a $10.00 price target on shares of Cutera in a research note on Friday, December 22nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cutera currently has a consensus rating of “Hold” and a consensus target price of $21.80.

Read Our Latest Stock Analysis on CUTR

Cutera Stock Down 1.1 %

CUTR opened at $2.62 on Friday. Cutera, Inc. has a 12-month low of $1.38 and a 12-month high of $36.00. The stock has a market cap of $52.24 million, a price-to-earnings ratio of -0.68 and a beta of 1.78. The business has a 50 day moving average of $2.96 and a 200-day moving average of $6.03.

About Cutera

(Free Report)

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.

Recommended Stories

Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTRFree Report).

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.